Mindray controlling shareholder releases significant share pledge

Magnifice (HK) Limited, the controlling shareholder of Shenzhen Mindray Bio-Medical Electronics, has completed the release of a pledge on 5,200,000 shares. This transaction represents 1.75% of Magnifice (HK)'s total shareholding and 0.43% of the company's total share capital. The pledge, originally established on November 26, 2024, with CMB Wing Lung Bank Limited, was officially released on September 29, 2025.

Following this release, Magnifice (HK) Limited now has 30,750,000 shares remaining under pledge, which constitutes 10.36% of its total holdings and 2.54% of the company's total share capital. The combined pledged shares of Magnifice (HK) and Smartco Development, the controlling shareholder and its consistent action party, total 30,750,000 shares, representing 4.93% of their collective holdings and 2.54% of Mindray's total share capital.

The company affirmed that currently, there is no risk of a forced liquidation of the pledged shares. Should such a risk emerge in the future, the shareholders are committed to taking proactive measures, and the company will fulfill its information disclosure obligations.